-
L-NAME Hydrochloride for Vascular Research
2026-08-22
Use L-NAME Hydrochloride as a controlled nitric oxide synthase perturbation tool across organ-bath, cellular, and cardiovascular workflows. Its greatest value is mechanistic: it can distinguish NO-dependent relaxation from prostaglandin and receptor-linked responses when paired with rescue experiments and orthogonal readouts.
-
Ferroptosis Signature Identifies Atorvastatin in HCC
2026-08-21
A 2025 study integrated ferroptosis-related transcriptomics, survival modeling, and Connectivity Map screening to develop a four-gene prognostic signature for hepatocellular carcinoma (HCC) and identify Atorvastatin as a candidate treatment. In vitro and in vivo experiments supported atorvastatin-associated ferroptosis and suppression of HCC growth and migration, while also highlighting the need for independent validation before clinical translation.
-
WAY-100635: 5-HT1A Assay Workflow Guide
2026-08-20
This scenario-based guide explains how WAY-100635 (SKU A3933) can clarify 5-HT1A-dependent effects in receptor-binding, functional, and cell-based workflows. It covers solvent compatibility, controls, storage, interpretation, and practical vendor-selection criteria for reproducible serotonin receptor antagonist research.
-
Caspofungin Workflows for Candida Research
2026-08-20
Caspofungin provides a practical benchmark for probing fungal cell wall biosynthesis, profiling azole-resistant Candida, and validating antifungal assay design. This guide connects mechanism-focused in vitro workflows with the delayed-treatment model used to evaluate invasive Candida auris infection.
-
Dabigatran Evidence in Thromboembolic Disorders
2026-08-19
The 2015 review by Enriquez and colleagues examined dabigatran as the first widely introduced non-vitamin K oral anticoagulant, integrating pharmacology with evidence from atrial fibrillation, venous thromboembolism, and orthopedic prophylaxis. Its practical contribution is a balanced interpretation: dabigatran offers predictable anticoagulation and less routine monitoring, but renal elimination, P-glycoprotein interactions, and bleeding management remain decisive.
-
MitMAB for Organoid Endocytosis Research
2026-08-19
MitMAB enables dynamin-focused perturbation of extracellular vesicle uptake in polarized intestinal organoids, helping distinguish surface access from intracellular trafficking. This workflow combines a defined chemical inhibitor with apical-out, basal-out, and monolayer models for more mechanistic endocytosis research.
-
Machine Learning for Senolytic Discovery
2026-08-18
The reference study shows that cost-effective machine-learning models trained only on published screening data can identify senolytic candidates from chemical libraries. Validation in human cell systems identified ginkgetin, periplocin, and oleandrin, supporting data-efficient approaches to early-stage senolytic discovery while highlighting the need for careful cell-state and selectivity controls.
-
CAY10499: Human HSL Inhibitor Guide
2026-08-18
This scenario-based guide explains how CAY10499, a potent inhibitor of human hormone sensitive lipase and monoglyceride lipase, can improve the interpretation of lipid-linked viability, proliferation, and cytotoxicity experiments. It covers assay compatibility, dose selection, data interpretation, storage, and vendor reliability for SKU B7841.
-
Tunicamycin for ER Stress Research
2026-08-17
Tunicamycin is a practical N-glycosylation inhibitor for creating controlled ER stress models in macrophages and endothelial cells. This guide connects formulation, dose-timing design, inflammatory readouts, and the ATF6–TRIM10–NF-κB findings of a recent hepatectomy study.
-
Cefoperazone: From MIC Data to Model Design
2026-08-17
Cefoperazone sodium salt supports more than routine susceptibility testing. This article translates comparative MIC, bactericidal, β-lactamase, and biliary distribution evidence into better assay and infection-model decisions.
-
Eicosapentaenoic Acid: Assay Design and Mechanism
2026-08-16
Explore how Eicosapentaenoic Acid functions as an EPA omega-3 fatty acid in membrane, vascular, and lipid-oxidation assays. This guide also explains how recent arachidonic acid vaccine research informs—not validates—practical EPA assay design.
-
Topotecan (SKF104864) Assay Workflows
2026-08-15
Topotecan (SKF104864) gives cancer researchers a practical way to model topoisomerase I–dependent replication stress across glioma, pediatric tumor, and combination-treatment systems. This workflow-focused guide connects dose design, apoptosis readouts, cell-cycle analysis, and troubleshooting to reproducible in vitro experiments.
-
Maternal Deltamethrin Exposure, Ferroptosis, and Memory
2026-08-14
The reference study links maternal deltamethrin exposure with impaired hippocampal learning and memory in male offspring through a p53-associated ferroptosis mechanism. Its combination of developmental animal testing, hippocampal molecular profiling, calcium-homeostasis analysis, and HT-22 cell interventions provides a framework for distinguishing oxidative injury from regulated ferroptotic signaling.
-
Atrial Natriuretic Peptide: Applied Research Workflows
2026-08-14
Build reproducible ANP assays for vascular tone, renal sodium handling, and adipose metabolism with practical controls for peptide handling and response timing. A reference-study-inspired framework also shows how to separate ANP biology from adiponectin-mediated inflammatory mechanisms without overextending the evidence.
-
Lisinopril dihydrate in Applied ACE Research
2026-08-13
Lisinopril dihydrate provides a water-compatible route to perturb ACE activity in hypertension, heart failure, myocardial infarction, and renal disease models. This workflow-focused guide connects compound handling with orthogonal enzyme controls, endpoint selection, and troubleshooting for more interpretable results.